LEADING LIFE SCIENCE ADVISORY FIRMS LAUNCH SYNAPTIQ HEALTH – A COLLECTIVE DELIVERING INTEGRATED MARKET RESEARCH, COMMUNICATIONS AND ACCESS SERVICES

London, [6th February 2020] A new life science powerhouse in market research, communications and access launches today. Genactis, emotive and Initiate have joined forces to create Synaptiq Health, a formal collection of individual best-in-class agencies and consultancies. Synaptiq Health will provide integrated or stand-alone support services across three key components critical to product success; INSIGHT, ENGAGEMENT and ACCESS.

INSIGHT: With more than 15 years of global experience, Genactis is a market research consultancy partnering with the world’s leading pharmaceutical and biotech companies to help identify core insights and power strategic decisions. ENGAGEMENT: emotive is a London- and Boston-based, award-winning healthcare communications agency, working with clients for more than 10 years to transform lives by engaging with healthcare professionals and others in the care pathway. ACCESS: Initiate is a global market access and strategy consultancy whose principals have several decades of experience in both consultancy and industry across multiple therapy areas.

With offices throughout Europe and the US, Synaptiq Health delivers an integrated platform that allows clients to focus on their core activities whilst knowing that their market research, communications and access needs are supported by individual world-class partners. Each provides unique skills and deeprooted expertise, all delivered with the same highest levels of dedication, service and experience.

Chris Edmonds, who is taking the role of founding CEO of Synaptiq Health, commented; “It has been clear that our clients, whether large pharma, medtech or biopharm, require a broad range of services to help them successfully develop, launch and maintain products. Synaptiq Health provides this. Our new approach brings together experts from their respective fields, and allows our clients to benefit from the breadth and depth of support required to realise the potential of their new, life-transforming treatments. The logic of an integrated approach, based on common scientific and commercial data and information, is powerful.”

With ambitious growth plans for the coming years, Synaptiq Health are already in talks with other  potential partner companies about joining the collection, where they can provide additional complementary services to clients.

To learn how Synaptiq Health can help you succeed in the pre-, peri- and post-launch stages  of the product lifecycle, contact Chris Edmonds on chris.edmonds@synaptiqhealth.com or call +44 0207 148 0408